You searched for "implant"
Surgery technique for subluxation in Marfan syndrome
The authors evaluated the efficacy and safety of bimanual capsulorrhexis combined with sutureless scleral-fixated IOL implant in children with Marfan syndrome. Seven children (14 eyes) with subluxated lenses underwent bilateral surgery; four female, three male with mean age of 7.1...
Refractive surgery for anisometropic amblyopia
The authors report the outcomes of refractive surgery with phakic intraocular lens (PIOL) implant for management of anisometropic amblyopia in children intolerant to conventional therapy. This was a retrospective study of 71 eyes of 71 patients of which 58 were...
Autologous scleral button for anterior defect in evisceration surgery
This is a small case series of five patients who have had evisceration surgery using a new technique. The anterior defect created when removing the corneal button has been closed by taking an autologous posterior scleral graft inferomedial to the...
Methotrexate and mycophenolate mofetil for non-infectious uveitis
This is the first reported randomised clinical trial comparing methotrexate versus mycophenolate mofetil (MMF) for the treatment of non-infectious intermediate uveitis, posterior uveitis or panuveitis. To be eligible for recruitment, patients had to be on ≥15mg oral prednisone and demonstrated...Glaukos at the Royal College of Ophthalmologists Annual Congress 2019 – Stand 17b
Glaukos, the ophthalmic medical technology company dedicated solely to the transformation of the treatment of glaucoma, is delighted to be attending the Annual Congress in Glasgow in May 2019. Glaukos has a portfolio of cutting edge products including the revolutionary...Strategies for managing neovascular AMD and DMO in routine clinical care
Treatment practice in the management of neovascular age-related macular degeneration (AMD) and diabetic macular oedema (DMO) illustrate increasing adoption of patient-tailored treatment approaches based on initial diagnosis and regular monitoring of imaging and visual outcomes in routine clinical care. The...The role of inflammation in the pathophysiology of DMO
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...United Kingdom and Eire Glaucoma Society (UKEGS) Conference: Last chance for Early Bird tickets!
The United Kingdom and Eire Glaucoma Society (UKEGS) invites you to its annual conference, hosted by Consultant Ophthalmologist Nishani Amerasinghe, on 9 and 10 October 2024 at the National Oceanography Centre in Southampton.Corporate M&A pace gathers momentum
Intensifying franchise competition, maturing product development pipelines and looming loss of exclusivity spur renewed merger and acquisition (M&A) activity in the ophthalmics sector. Rod McNeil reviews recent deals and related strategic developments. AbbVie to acquire Allergan in $63 billion mega-combination,...Rare eye diseases: progress continues with authorised orphan medicines and breakthrough technologies
An update on the development of orphan medicines, recent regulatory treatment approvals for rare eye conditions and advances in retinal prosthetic technologies for blinding diseases. The prevalence of a rare disease is based usually on a range of estimates and...
